XTX Topco’s Redhill Biopharma RDHL Stock Holding History

XTX Topco’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,163	Closed	-$11.3K	–	4614
2026 Q1	$11.3K	Buy	+15,163	New	+$16K	﹤0.01%	3661

Other funds holding RDHL

YAG

Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

XTX Topco's RDHL Position: Q2 2026 in Review

XTX Topco sold out of Redhill Biopharma (RDHL) in Q2 2026, closing a stake of 15,163 shares — an estimated $11.3K sold.

XTX Topco first reported a position in RDHL in Q1 2026 and held it in 1 quarter. The position peaked at $11.3K in Q1 2026. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

XTX Topco reported no remaining Redhill Biopharma position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 15,163 Redhill Biopharma shares in Q2 2026, an estimated $11.3K.
XTX Topco first reported a position in Redhill Biopharma in Q1 2026 and held it in 1 quarter.
XTX Topco's Redhill Biopharma position peaked at $11.3K in Q1 2026.
14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.